Related Experiment Video
Updated: Nov 9, 2025

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
Zonisamide as treatment option in persistent migraine aura
Katharina Kaltseis1, Florian Frank1, Gregor Broessner2
1Neurology, Innsbruck Medical University Department of Neurology, Innsbruck, Austria.
Zonisamide effectively treated prolonged migraine aura in a patient with triple X syndrome. This finding suggests zonisamide as a new, safe option for persistent migraine aura refractory to other treatments.
Area of Science:
- Neurology
- Clinical Case Study
Background:
- Persistent migraine aura without infarction is a rare, debilitating neurological condition.
- Current treatment options for persistent migraine aura are limited, often anecdotal, and associated with inefficacy and side effects.
Related Concept Videos
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Management of Insomnia
Mania and Antimanic Drugs: Overview
Psychosis: Goals of Pharmacotherapy
Antidepressant Drugs: MAOIs and Other Agents
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

